Literature DB >> 16188653

Platelets in sepsis.

Marcel Levi1.   

Abstract

Platelets are circulating blood cells that will normally not interact with the intact vessel wall but that may swiftly respond to vascular disruption by adhering to subendothelial structures, followed by interaction with each other, thereby forming a platelet aggregate. The activated platelet (phospholipid) membrane may form a suitable surface on which further coagulation activation may occur. These processes are part of the first line of defence of the body against bleeding but may also contribute to pathological thrombus formation in vascular disease, such as thrombus formation on top of a ruptured atherosclerotic plaque. In case of systemic inflammatory syndromes, such as the response to sepsis, disseminated intravascular platelet activation may occur, which will contribute to microvascular failure and thereby play a role in the development of organ dysfunction. In addition, in this situation platelets may be directly involved in the inflammatory response by releasing inflammatory mediators and growth factors.

Entities:  

Mesh:

Year:  2005        PMID: 16188653     DOI: 10.1080/10245330512331390177

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  21 in total

1.  A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multiple organ injury.

Authors:  Brian D Kubiak; Scott P Albert; Louis A Gatto; Christopher J Vieau; Shreyas K Roy; Kathleen P Snyder; Kristopher G Maier; Gary F Nieman
Journal:  J Surg Res       Date:  2010-11-12       Impact factor: 2.192

2.  Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape.

Authors:  Lisbeth Svensson; Maria Baumgarten; Matthias Mörgelin; Oonagh Shannon
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  Sepsis-induced heparin resistance during extracorporeal membrane oxygenation.

Authors:  Ali Hage; Martha Louzada; Bob Kiaii
Journal:  CMAJ       Date:  2019-03-11       Impact factor: 8.262

Review 4.  The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.

Authors:  Karen M Hook; Charles S Abrams
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

Review 5.  Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.

Authors:  Colin E Evans; You-Yang Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

6.  Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.

Authors:  Binggang Xiang; Guoying Zhang; Ling Guo; Xiang-An Li; Andrew J Morris; Alan Daugherty; Sidney W Whiteheart; Susan S Smyth; Zhenyu Li
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance.

Authors:  Anat Gafter-Gvili; Nariman Mansur; Assaf Bivas; Noa Zemer-Wassercug; Jihad Bishara; Leonard Leibovici; Mical Paul
Journal:  Mayo Clin Proc       Date:  2011-05       Impact factor: 7.616

8.  A microfluidics approach towards high-throughput pathogen removal from blood using margination.

Authors:  Han Wei Hou; Hiong Yap Gan; Ali Asgar S Bhagat; Leon D Li; Chwee Teck Lim; Jongyoon Han
Journal:  Biomicrofluidics       Date:  2012-05-01       Impact factor: 2.800

9.  Fructose-1,6-bisphosphate inhibits in vitro and ex vivo platelet aggregation induced by ADP and ameliorates coagulation alterations in experimental sepsis in rats.

Authors:  Luciana M de Oliveira; Melissa G Simões Pires; Alessandra B Magrisso; Terezinha P Munhoz; Rafael Roesler; Jarbas R de Oliveira
Journal:  J Thromb Thrombolysis       Date:  2009-08-25       Impact factor: 2.300

10.  Septic shock and chemotherapy-induced cytopenia: effects on microcirculation.

Authors:  Thomas Karvunidis; Jiri Chvojka; Daniel Lysak; Roman Sykora; Ales Krouzecky; Jaroslav Radej; Ivan Novak; Martin Matejovic
Journal:  Intensive Care Med       Date:  2012-05-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.